Sign In
Buy SCPH
$5.67
+0 (+0%)
At Close: Jan 06, 2026
Recent Price Trend in scPharmaceuticals, Inc. (SCPH) is Your Friend, Here's Why
10:32am, Monday, 06'th Feb 2023
scPharmaceuticals, Inc. (SCPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made
scPharmaceuticals: Undervalued, De-Risked Cardiology Commercial Biotech, Initiating With A Buy
08:15am, Tuesday, 24'th Jan 2023
scPharma is a small-cap biotech with a cardiology product, Furoscix, that was approved last October, expected to launch in 1Q 2023. We believe Furoscix is derisked as furosemide (loop diuretics) is th
scPharmaceuticals, Inc. (SCPH) Is a Great Choice for 'Trend' Investors, Here's Why
10:32am, Monday, 02'nd Jan 2023
scPharmaceuticals, Inc. (SCPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made
What Makes scPharmaceuticals, Inc. (SCPH) a New Buy Stock
01:32pm, Tuesday, 20'th Dec 2022
scPharmaceuticals, Inc. (SCPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Has scPharmaceuticals (SCPH) Outpaced Other Medical Stocks This Year?
11:17am, Tuesday, 20'th Dec 2022
Here is how scPharmaceuticals, Inc. (SCPH) and Syndax Pharmaceuticals (SNDX) have performed compared to their sector so far this year.
scPharmaceuticals Inc. (SCPH) Q3 2022 Earnings Call Transcript
04:57pm, Saturday, 12'th Nov 2022
scPharmaceuticals Inc. (NASDAQ:SCPH ) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET Company Participants Hans Vitzthum - IR John Tucker - CEO Rachael Nokes - SVP, Finance Steve Parsons -
scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients
04:05am, Thursday, 20'th Oct 2022
After two CRLs, FUROSCIX has finally received FDA approval. This treatment could be a game-changer in the treatment of heart failure, allowing certain patients to avoid costly hospitalizations altoget
scPharmaceuticals (SCPH) Plunges Despite Furoscix's FDA Approval
06:48pm, Tuesday, 11'th Oct 2022
scPharmaceuticals (SCPH) receives FDA approval for its proprietary heart failure therapy. It also reported a debt refinancing agreement to help with the drug launch.
Why Is scPharmaceuticals (SCPH) Stock in the Spotlight Today?
11:27am, Monday, 10'th Oct 2022
There were not just one, but two press releases from scPharmaceuticals (NASDAQ: SCPH ) this morning. Apparently, the U.S. Food and Drug Administration (FDA) approved Furoscix.
scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
08:00am, Thursday, 01'st Sep 2022
BURLINGTON, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to opti
scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 17'th May 2022
BURLINGTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimi
scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference
09:05pm, Wednesday, 16'th Feb 2022 GlobeNewswire
BURLINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 42 nd Annual Cowen Healthcare Conference on Tuesday, March 8 at 1:30pm EST.
scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference
04:05pm, Wednesday, 16'th Feb 2022
BURLINGTON, Mass., Feb. 16, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optim
scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
08:00am, Thursday, 03'rd Feb 2022
BURLINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optim
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
04:05pm, Monday, 20'th Dec 2021
BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optim
